Trial Outcomes & Findings for Asthma and Obesity: Pilot Study (NCT NCT04113746)

NCT ID: NCT04113746

Last Updated: 2022-11-14

Results Overview

BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

27 participants

Primary outcome timeframe

At 30 days Post-pilot follow-up visit, up to 2 months

Results posted on

2022-11-14

Participant Flow

Recruitment began in May 2019 with enrollment from Oct 2019-April 2021 at Icahn School of Medicine at Mount Sinai and University of Colorado, Denver)

Participant milestones

Participant milestones
Measure
Asthma and Exercise Lifestyle Change
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Overall Study
STARTED
13
14
Overall Study
COMPLETED
9
10
Overall Study
NOT COMPLETED
4
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Asthma and Exercise Lifestyle Change
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Overall Study
Lost to Follow-up
4
4

Baseline Characteristics

Asthma and Obesity: Pilot Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Asthma and Exercise Lifestyle Change
n=13 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=14 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Total
n=27 Participants
Total of all reporting groups
Age, Continuous
47.2 years
STANDARD_DEVIATION 10.7 • n=5 Participants
48.7 years
STANDARD_DEVIATION 14.8 • n=7 Participants
48 years
STANDARD_DEVIATION 12.7 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
13 Participants
n=7 Participants
25 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
n=5 Participants
5 Participants
n=7 Participants
9 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=5 Participants
8 Participants
n=7 Participants
15 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
3 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
4 Participants
n=5 Participants
5 Participants
n=7 Participants
9 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Body Mass Index (BMI)
37 kg/m^2
STANDARD_DEVIATION 6.5 • n=5 Participants
39.6 kg/m^2
STANDARD_DEVIATION 8.7 • n=7 Participants
38.2 kg/m^2
STANDARD_DEVIATION 7.5 • n=5 Participants
Marital Status
Married
3 Participants
n=5 Participants
7 Participants
n=7 Participants
10 Participants
n=5 Participants
Marital Status
Unmarried
10 Participants
n=5 Participants
7 Participants
n=7 Participants
17 Participants
n=5 Participants
Language
English
12 Participants
n=5 Participants
12 Participants
n=7 Participants
24 Participants
n=5 Participants
Language
Spanish
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Monthly Income
Less than $3000
9 Participants
n=5 Participants
10 Participants
n=7 Participants
19 Participants
n=5 Participants
Monthly Income
More than $3000
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Monthly Income
Missing/refused
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Education
Elementary
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Education
Any High School
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
Education
High School Graduate
5 Participants
n=5 Participants
1 Participants
n=7 Participants
6 Participants
n=5 Participants
Education
Any College
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Education
College Graduate
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
Education
Higher Degree
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Insurance
Medicare
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Insurance
Medicaid
7 Participants
n=5 Participants
6 Participants
n=7 Participants
13 Participants
n=5 Participants
Insurance
Medicare and Medicaid
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Insurance
Private
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Insurance
Missing
3 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At 30 days Post-pilot follow-up visit, up to 2 months

BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=9 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=10 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Beliefs About Illness Perception Questionnaire (BIPQ)
42.6 score on a scale
Standard Deviation 11.4
36.2 score on a scale
Standard Deviation 8.2

SECONDARY outcome

Timeframe: At 30 days Post-pilot follow-up visit, up to 2 months

Population: Data only obtained from participants on a controller medication.

MARS is a self-reported questionnaire with the total score range from 0-10 with a higher score indicating better adherence.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=7 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=9 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Medication Adherence Rating Scale (MARS)
4.7 score on a scale
Standard Deviation 0.5
4.7 score on a scale
Standard Deviation 0.5

SECONDARY outcome

Timeframe: Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Population: Data for participants with accelerometers with valid analyzable data.

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer will measure step counts using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time will be considered a valid measure of usual activity.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=3 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=4 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Physical Activity - Step Counts Per Day
Week 2
12253.3 steps/day
Standard Deviation 0
2499.7 steps/day
Standard Deviation 1514.9
Physical Activity - Step Counts Per Day
Week 4
13730.2 steps/day
Standard Deviation 0
2123.9 steps/day
Standard Deviation 1751.0
Physical Activity - Step Counts Per Day
at 30 days post pilot follow-up visit
2667.9 steps/day
Standard Deviation 375.4
3715.1 steps/day
Standard Deviation 3041.5

SECONDARY outcome

Timeframe: Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Population: Data for participants with accelerometers with valid analyzable data.

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer measured time spent in different intensities of activity using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time was considered a valid measure of usual activity.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=5 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=6 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Time in Physical Activity
at 30 days post pilot follow-up visit
9.9 minutes/day
Standard Deviation 6.8
7.8 minutes/day
Standard Deviation 9.2
Time in Physical Activity
Week 2
74.5 minutes/day
Standard Deviation 0
8.6 minutes/day
Standard Deviation 7.0
Time in Physical Activity
Week 4
91.5 minutes/day
Standard Deviation 0
10.3 minutes/day
Standard Deviation 8.3

SECONDARY outcome

Timeframe: at 30 days Post-pilot follow-up visit, up to 2 months

Asthma Control Questionnaire (ACQ) - self-reported asthma control validated survey, with a total score range from 0-6, with a higher score indicating severely uncontrolled asthma, used to assess current asthma control at 30 days post-pilot follow up visit.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=9 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=10 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Control Questionnaire (ACQ)
1.6 score on a scale
Standard Deviation 1.0
1.3 score on a scale
Standard Deviation 0.9

SECONDARY outcome

Timeframe: at 30 days post-pilot follow-up visit, up to 2 months

Asthma Quality of Life Questionnaire (AQLQ) - self-reported asthma-related quality of life validated survey used to assess asthma-related quality of life at 30 days post-pilot follow-up visit. Total Score from 1-7, with higher score indicating better quality of life.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=9 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=10 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Quality of Life Questionnaire (AQLQ)
4.9 score on a scale
Standard Deviation 0.8
5.0 score on a scale
Standard Deviation 0.6

SECONDARY outcome

Timeframe: at 30 days post pilot follow-up visit, up to 2 months

Beliefs about Medications Questionnaire (BMQ) - Necessity and Concerns The BMQ comprises two separate two five-item sub-scales (Necessity and Concerns) and assesses respondents' beliefs about prescribed medicines that they are currently using for specific conditions, for e.g. asthma. It assesses patients' beliefs about the necessity of prescribed medication for controlling their disease and their concerns about potential adverse consequences of taking it. Respondents indicate their degree of agreement with each statement on a five-point Likert scale, ranging from 1 - strongly disagree to 5 - strongly agree. Each subscale is scored from 5 -25. Scores obtained for individual items within both scales are summed. Thus, total scores for the Necessity and Concerns Scales range from 10-50. Higher scores indicate stronger beliefs in necessity or more concerns.

Outcome measures

Outcome measures
Measure
Asthma and Exercise Lifestyle Change
n=9 Participants
Participants receive asthma and lifestyle change education related to exercise Participants in the asthma and exercise lifestyle change arm participated in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Asthma Education
n=10 Participants
No lifestyle change education Asthma Education: General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants used the accelerometer to track activity, but was blinded to the data.
Beliefs About Medications Questionnaire (BMQ) - Necessity and Concerns Subscale
Necessity Subscale
15 score on a scale
Standard Deviation 3.6
16.4 score on a scale
Standard Deviation 5
Beliefs About Medications Questionnaire (BMQ) - Necessity and Concerns Subscale
Concerns Subscale
8.4 score on a scale
Standard Deviation 1
8.4 score on a scale
Standard Deviation 2.7

Adverse Events

Asthma and Exercise Lifestyle Change

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Asthma Education

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Juan P. Wisnivesky, MD, DrPH

Icahn School of Medicine at Mount Sinai

Phone: 212-824-7567

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place